Successful Treatment of Hypocomplementemic Urticarial Vasculitis With Omalizumab: A Case Report

J Investig Allergol Clin Immunol. 2020 Jun;30(3):211-212. doi: 10.18176/jiaci.0486.
No abstract available

Keywords: Hypocomplementemic; Omalizumab; Treatment; Urticarial vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Complement C1q / genetics
  • Female
  • Hereditary Complement Deficiency Diseases / drug therapy*
  • Humans
  • Immunoglobulin E / immunology
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Treatment Outcome
  • Urticaria / drug therapy*
  • Vasculitis / drug therapy*

Substances

  • Omalizumab
  • Immunoglobulin E
  • Complement C1q